Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on quality of life and patient oriented outcomes with external experts

Chernyshov, Pavel V., Tomas-Aragones, Lucia, Manolache, Liana, Pustisek, Nives, Salavastru, Carmen Maria, Marron, Servando E., Bewley, Anthony, Svensson, Ake, Poot, Françoise, Suru, Alina, Salek, Sam S., Augustin, Matthias, Szepietowski, Jacek, Koumaki, Dimitra, Katoulis, Alexander C., Sampogna, Francesca, Abeni, Damiano, Linder, Dennis Michael, Speeckaert, Reinhart, van Geel, Nanja, Seneschal, Julien, Ezzedine, Khaled and Finlay, Andrew Y. ORCID: https://orcid.org/0000-0003-2143-1646 2023. Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on quality of life and patient oriented outcomes with external experts. Journal of the European Academy of Dermatology and Venereology 37 (1) , pp. 21-31. 10.1111/jdv.18593

Full text not available from this repository.

Abstract

Members of the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life (QoL) and Patient Oriented Outcomes reviewed the instruments available for health-related (HR) QoL assessment in vitiligo and together with external vitiligo experts (including representatives of the EADV Vitiligo Task Force) have made practical recommendations concerning the assessment of QoL in vitiligo patients. The Dermatology Life Quality Index (DLQI) was the most frequently used HRQoL instrument, making comparison of results between different countries possible. Several vitiligo-specific instruments were identified. The vitiligo Impact Scale (VIS) is an extensively validated vitiligo-specific HRQoL instrument with proposed minimal important change and clinical interpretation for VIS-22 scores. VIS-22 was developed for use in India, where there are some specific cultural beliefs concerning vitiligo. The EADV Task Force on QoL and Patient Oriented Outcomes recommends use of the DLQI and the Children's Dermatology Life Quality Index (CDLQI) as dermatology-specific instruments in vitiligo. There is a strong need for a valid (including cross-cultural validation) vitiligo-specific instrument that can be either a new instrument or the improvement of existing instruments. This validation must include the proof of responsiveness.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Wiley
ISSN: 0926-9959
Date of Acceptance: 13 September 2022
Last Modified: 11 Apr 2023 10:15
URI: https://orca.cardiff.ac.uk/id/eprint/158454

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item